Canada markets open in 2 hours 43 minutes

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
0.9500-0.0600 (-5.94%)
At close: 04:00PM EDT
0.9280 -0.02 (-2.32%)
Pre-Market: 06:24AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.0100
Open1.0300
Bid0.0000 x 800
Ask0.9500 x 2200
Day's Range0.9250 - 1.0300
52 Week Range0.9250 - 2.5450
Volume43,910,238
Avg. Volume22,542,482
Market Cap2.045B
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets

    Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline. These assets will be integrated into Ginkgo Ag Biologicals Services, established with the acquisition of a Bayer agricultural biologicals R&D fa

  • PR Newswire

    Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"

    Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its 5th annual Ferment conference. The conference brings together stakeholders from across the synthetic biology community, including R&D leaders, Ginkgo Technology Network partners, experts from across academia, journalists, and many more. Because the event has reached its in-person capacity limits, a livestream will be available on Ginkgo's YouTube page and Ginkgo's Inves

  • PR Newswire

    Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain

    Ginkgo Bioworks (NYSE: DNA), which is developing the leading platform for cell programming and biosecurity, today announced the expansion of its strategic partnership with global healthcare leader Novo Nordisk under a framework agreement that initially is contemplated to run over five years.